Kindly sponsored by


Dr. Youness Ahallal is a leading urologist and robotic surgeon based in Casablanca, Morocco. With extensive training in New York and France, he specializes in advanced robotic and minimally invasive surgery. Dr. Ahallal is a pioneer in the field, having performed a world-first telesurgery operation from Shanghai to Casablanca. Committed to innovation, he actively promotes the development of robotic surgery and telemedicine across Morocco and Africa. A sought-after speaker, he shares insights on the future of digital health and medical technology. Dr. Ahallal’s work bridges cutting-edge technology with patient care, shaping the future of surgery in the region.

Dr Andrew Loblaw is a Radiation Oncologist, Clinician Scientist, and dual Professor in the Department of Radiation Oncology and the Institute of Health Policy Management & Evaluation at the University of Toronto. He’s the Site Group Co-Lead for Genitourinary Oncology at Sunnybrook. He received a Bachelor of Science in Physics from the University of British Columbia and his Doctor of Medicine from Queen’s University. He completed his specialty training in Radiation Oncology concurrent with a Masters degree in Clinical Epidemiology to graduate from the Royal College’s Clinician Investigator Program all at the University of Toronto. Dr Loblaw’s clinical practice and research interest focus on improving outcomes for men with prostate cancer and the healthcare system. He has a particularly interest in the design and conduct of clinical trials, the generation and dissemination of evidence-based guidelines and in image-guided radiotherapy. Dr Loblaw is an Ontario Association of Radiation Oncology Clinician Scientist and a Senior Scientist at the Sunnybrook Research Institute. A Fellow of the American Society of Clinical Oncology (FASCO), he was previous Co-Chair of the ASCO’s Genitourinary Advisory Group and remains Co-Chair of the GU group for Cancer Care Ontario’s Program in Evidence-Based Care. He has authored over 325 peer-reviewed papers and has been awarded grant funding of over Cdn$52M.

Kindly sponsored by


A/Professor James Porter, is Director of Robotic Surgery for Providence St. Joseph Health and Swedish Medical Center. He is the most experienced robotic surgeon in the Pacific Northwest and has performed over 5000 robotic procedures. He is Director of the Robotic and Laparoscopic Fellowship in Urology at Swedish Medical Center over the last 22 years. He is recognized as a national and international leader in robotic surgery and is active in teaching robotic surgical techniques to surgeons around the globe. He pioneered the retroperitoneal approach for robotic renal surgery as well as retroperitoneal lymph node dissection for the treatment of testicular cancer.

Kindly sponsored by


Prof. Tobias Maurer, FEBU, is a renowned urologist at the Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, with a clinical and scientific focus on prostate cancer, particularly in the fields of imaging, surgery, and medical therapy. He is a leading expert in PSMA-PET imaging and PSMA-radioguided surgery, with over 285 scientific publications and an h-index of 62. Prof. Maurer has served as principal or co-investigator in more than 30 clinical trials and has received over 30 national and international awards, including the DGU Research and Innovation Award for PSMA-radioguided surgery.

Michael Ng is a Radiation Oncologist at GenesisCare with an MBBS (Hons) from Monash University. He trained at the Peter MacCallum Cancer Centre, completed his fellowship at the Royal Marsden Hospital, UK and has worked as full-time consultant at GenesisCare Victoria since 2009, specialising in prostate, breast, gastrointestinal, and lung cancers. He is a clinical associate professor with the Department of Medicine at Melbourne University, leads the stereotactic radiation therapy service in GenesisCare Victoria, and served as the radiotherapy chair of EviQ cancer guidelines and on the Australian Government’s Medical Services Advisory Committee.

Professor Henk van der Poel is head of the department of urology at the Netherlands Cancer Center in Amsterdam (NL) and endowed-professor the Free-University, Amsterdam (NL). Main focuses of research are the role of image-guided surgery in the management of urological oncological diseases and the perioperative network cancer-care for prostate cancer. He is editor-in-chief of the Dutch Journal of Urology.